CAS: 2102933-95-7
Ref: IN-DA01EO5W
| 5mg | 196.00 € | ||
| 10mg | 197.00 € |
Estimated delivery in United States, on Wednesday 11 Dec 2024
GSK-LSD1 dihydrochloride
CAS:2102933-95-7
GSK-LSD1 dihydrochloride: potent LSD1 inhibitor, >1000x selective over MAO-A/B, LSD2, IC50: 16 nM.
Formula:
C14H22Cl2N2
Purity:
100% - 99.22%
Color and Shape:
Solid
Molecular weight:
289.24
Ref: TM-T2315
| 1mg | 40.00 € | ||
| 2mg | 52.00 € | ||
| 5mg | 70.00 € | ||
| 10mg | 101.00 € | ||
| 25mg | 206.00 € | ||
| 50mg | 312.00 € | ||
| 100mg | 513.00 € | ||
| 500mg | 1,093.00 € | ||
| 1mL*10mM (DMSO) | 71.00 € |
Estimated delivery in United States, on Wednesday 18 Dec 2024
GSK LSD1 Dihydrochloride
Controlled ProductCAS:2102933-95-7
Applications GSK LSD1 Dihydrochloride is an irreversible mechanism-based inhibitor of LSD1. Lysine-specific demthylase 1 (LSD1) …
Formula:
C14H22Cl2N2
Color and Shape:
Neat
Molecular weight:
342.407
Ref: TR-G797570
| 100mg | 2,172.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
GSK-LSD1 dihydrochloride
CAS:2102933-95-7
GSK-LSD1 is a potential drug for the treatment of cervical cancer and myeloid leukemia. GSK-LSD1 …
Formula:
C14H22Cl2N2
Purity:
Min. 95%
Molecular weight:
289.24 g/mol
Ref: 3D-CJD93395
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Wednesday 22 Jan 2025
